What changed
$GWRE — BUY 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ3 FY2026 (ends Apr) | reported Jun 04 | Rev $373M | EPS $0.82 vs $0.74 🟢 | Margin 8.2%
💡 Consensus expected $0.74 EPS, but actual $0.82 indicates upward estimate revisions ahead. The market prices GWRE at 37x trailing, assuming slow margin growth; however, the sharp sequential improvement suggests a re-rating as margins catch up to high growth.
📉 Reward/risk: 2.3:1
🏢 Business Quality: 6/10
📊 Valuation: rich — 37x trailing P/E, 6.8x annualized revenue; relative to high-growth SaaS peers, it's at the upper end, but justified if 20%+ growth and...
🔮 Catalyst: Next quarterly earnings report
💰 Entry: $121.48, stop $100.0, target $170.0
⚖️ Buy GWRE for 6-month upside on accelerating revenue and margin expansion; target $170, stop at $100 (reward/risk 2.3:1).